Introduction: Multiple sclerosis (MS) is an inflammatory, demyelinating, central nervous system disease that frequently causes pain. Areas covered: This article reviews the current literature and describes the therapeutic options for treating MS-related pain. The reader will be provided with current, evidence-based knowledge about the treatment of MS-related pain, and the review will take a practical approach to the various drugs for treating pain, including starting dose, titration and side effects. Expert opinion: Only cannabinoids have been assessed in randomized, controlled trials. Because of the concern regarding the risk of abuse and psychiatric adverse events, published guidelines as well as expert recommendations suggest using them as second-line therapy only. Hence, current treatment should be based on the general principles for treating peripheral neuropathic pain, taking into account drug-induced adverse effects.

Treating pain in multiple sclerosis / Truini, Andrea; Galeotti, Francesca; Cruccu, Giorgio. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - 12:15(2011), pp. 2355-2368. [10.1517/14656566.2011.607162]

Treating pain in multiple sclerosis

TRUINI, ANDREA;GALEOTTI, FRANCESCA;CRUCCU, Giorgio
2011

Abstract

Introduction: Multiple sclerosis (MS) is an inflammatory, demyelinating, central nervous system disease that frequently causes pain. Areas covered: This article reviews the current literature and describes the therapeutic options for treating MS-related pain. The reader will be provided with current, evidence-based knowledge about the treatment of MS-related pain, and the review will take a practical approach to the various drugs for treating pain, including starting dose, titration and side effects. Expert opinion: Only cannabinoids have been assessed in randomized, controlled trials. Because of the concern regarding the risk of abuse and psychiatric adverse events, published guidelines as well as expert recommendations suggest using them as second-line therapy only. Hence, current treatment should be based on the general principles for treating peripheral neuropathic pain, taking into account drug-induced adverse effects.
2011
cannabinoids; neuropathic pain; opioids; pregabalin; multiple sclerosis; antidepressant; venlafaxine; duloxetine
01 Pubblicazione su rivista::01a Articolo in rivista
Treating pain in multiple sclerosis / Truini, Andrea; Galeotti, Francesca; Cruccu, Giorgio. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - 12:15(2011), pp. 2355-2368. [10.1517/14656566.2011.607162]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/405382
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 24
social impact